People Background Check
Find People:

Giovanni Coppola, Age 5310 Hilltop Cir, Chappaqua, NY 10514

Get Report

Giovanni Coppola Phones & Addresses

Chappaqua, NY

3619 Shoreheights Dr, Malibu, CA 90265

10959 Rochester Ave, Los Angeles, CA 90024 (310) 473-7475

10989 Rochester Ave, Los Angeles, CA 90024 (310) 473-7475

Santa Monica, CA

Mentions for Giovanni Coppola

Giovanni Coppola resumes & CV records

Resumes

Giovanni Coppola Photo 29

Giovanni Coppola

Giovanni Coppola Photo 30

Giovanni Coppola

Publications & IP owners

Us Patents

Materials And Methods Of Treating Mhc-1-Opathy Risk Haplotypes

US Patent:
2022032, Oct 13, 2022
Filed:
Apr 6, 2022
Appl. No.:
17/714717
Inventors:
- Tarrytown NY, US
Ann Ligocki - Tarrytown NY, US
Giovanni Coppola - Tarrytown NY, US
Aris Baras - Tarrytown NY, US
Arden Moscati - Tarrytown NY, US
Eli A. Stahl - Tarrytown NY, US
Jack A. Kosmicki - Tarrytown NY, US
Manuel Allen Revez Ferreira - Tarrytown NY, US
Carmelo Romano - Tarrytown NY, US
International Classification:
A61K 39/395
A61K 31/713
C07K 16/28
C07K 16/40
Abstract:
The present disclosure provides methods of treating subjects having an immune disorder by administering to the subject a therapeutically effective amount of an Endoplasmic Reticulum Aminopeptidase 2 (ERAP2) inhibitor in combination with an HLA-A29 or HLA-B27 inhibitory nucleic acid molecule.

Treatment Of Psychiatric Disorders And Psychiatric Disorder-Associated Mri Phenotypes With Stabilin 1 (Stab1) Inhibitors

US Patent:
2023010, Apr 6, 2023
Filed:
Sep 29, 2022
Appl. No.:
17/936715
Inventors:
- Tarrytown NY, US
Veera Rajagopal - Tarrytown NY, US
Giovanni Coppola - Tarrytown NY, US
Jonathan Marchini - Tarrytown NY, US
Aris Baras - Tarrytown NY, US
International Classification:
C12N 15/113
A61P 25/18
Abstract:
The present disclosure provides methods of treating subjects having psychiatric disorders and/or psychiatric disorder-associated MRI phenotypes, and methods of identifying subjects having an increased risk of developing psychiatric disorders and/or psychiatric disorder-associated MRI phenotypes.

Treatment Of Glaucoma With Rho Guanine Nucleotide Exchange Factor 12 (Arhgef12) Inhibitors

US Patent:
2023009, Mar 30, 2023
Filed:
Sep 28, 2022
Appl. No.:
17/936244
Inventors:
- Tarrytown NY, US
Giovanni Coppola - Tarrytown NY, US
Manuel Allen Revez Ferreira - Tarrytown NY, US
Lauren Gurski - Tarrytown NY, US
Aris Baras - Tarrytown NY, US
Claudia Schurmann - Tarrytown NY, US
International Classification:
C12N 15/113
C08G 69/10
A61P 27/06
Abstract:
The present disclosure provides methods of treating subjects having glaucoma or elevated intraocular pressure (IOP), methods of identifying subjects having an increased risk of developing glaucoma or developing elevated IOP, methods of detecting human Rho Guanine Nucleotide Exchange Factor 12 (ARHGEF12) variant nucleic acid molecules and variant polypeptides, and ARHGEF12 variant nucleic acid molecules and variant polypeptides.

Modulation Of Endoplasmic Reticulum Aminopeptidase 2 (Erap2)-Mediated Immune Response

US Patent:
2023005, Feb 23, 2023
Filed:
Jul 23, 2021
Appl. No.:
17/384601
Inventors:
- Tarrytown NY, US
Ann Ligocki - Tarrytown NY, US
Giovanni Coppola - Tarrytown NY, US
Aris Baras - Tarrytown NY, US
Arden Moscati - Tarrytown NY, US
Eli A. Stahl - Tarrytown NY, US
Jack A. Kosmicki - Tarrytown NY, US
Manuel Allen Revez Ferreira - Tarrytown NY, US
Carmelo Romano - Tarrytown NY, US
International Classification:
C07K 16/28
C12N 15/113
A61K 31/713
A61K 38/08
A61K 45/06
Abstract:
The present disclosure provides methods of treating subjects having an immune disorder by administering a therapeutically effective amount of an Endoplasmic Reticulum Aminopeptidase 2 (ERAP2) inhibitor to the subject, and optionally an Endoplasmic Reticulum Aminopeptidase 1 (ERAP1) agonist or inhibitor and/or an HLA-Aw19 inhibitor, and also provides methods of identifying subjects having an increased risk for developing an MHC-I-opathy.

Treatment Of Cognitive Impairment With Alpha-N-Acetylgalactosaminide Alpha-2,6-Sialyltransferase 5 (St6Galnac5) Inhibitors

US Patent:
2023003, Feb 2, 2023
Filed:
Jun 30, 2022
Appl. No.:
17/854759
Inventors:
- Tarrytown NY, US
Manuel Allen Revez Ferreira - Tarrytown NY, US
Giovanni Coppola - Tarrytown NY, US
Goncalo Abecasis - Tarrytown NY, US
Aris Baras - Tarrytown NY, US
International Classification:
C12Q 1/6827
A61K 31/7105
C12N 15/113
C12N 9/22
C07K 14/47
C12Q 1/6883
Abstract:
The present disclosure provides methods of treating subjects having cognitive impairment or at risk of developing cognitive impairment, and methods of identifying subjects having an increased risk of developing cognitive impairment.

Solute Carrier Family 26 Member 5 (Slc26A5) Variants And Uses Thereof

US Patent:
2021037, Dec 2, 2021
Filed:
May 5, 2021
Appl. No.:
17/308563
Inventors:
- Tarrytown NY, US
Giovanni Coppola - Tarrytown NY, US
Manuel Allen Revez Ferreira - Tarrytown NY, US
Lauren Gurski - Tarrytown NY, US
Aris Baras - Tarrytown NY, US
Meghan Drummond Samuelson - Tarrytown NY, US
Goncalo Abecasis - Tarrytown NY, US
International Classification:
C12Q 1/6883
G01N 33/53
Abstract:
The present disclosure provides methods of treating a subject having hearing loss, methods of identifying a subject having an increased risk of developing hearing loss, and methods of detecting Solute Carrier Family 26 Member 5 (SLC26A5) variant nucleic acid molecules and variant polypeptides.

Kelch Domain Containing 7B (Klhdc7B) Variants And Uses Thereof

US Patent:
2021034, Nov 11, 2021
Filed:
May 4, 2021
Appl. No.:
17/307653
Inventors:
- Tarrytown NY, US
Giovanni Coppola - Tarrytown NY, US
Manuel Allen Revez Ferreira - Tarrytown NY, US
Lauren Gurski - Tarrytown NY, US
Aris Baras - Tarrytown NY, US
Meghan Drummond Samuelson - Tarrytown NY, US
Goncalo Abecasis - Tarrytown NY, US
International Classification:
C12Q 1/6874
C12Q 1/6876
C12Q 1/6851
G01N 33/68
Abstract:
The present disclosure provides methods of treating subjects having hearing loss, methods of identifying subjects having an increased risk of developing hearing loss, and methods of detecting Kelch Domain Containing 7B (KLHDC7B) variant nucleic acid molecules and variant polypeptides.

Fascin-2 (Fscn2) Variants And Uses Thereof

US Patent:
2021030, Sep 30, 2021
Filed:
Mar 5, 2021
Appl. No.:
17/194013
Inventors:
- Tarrytown NY, US
Giovanni Coppola - Tarrytown NY, US
Manuel Allen Revez Ferreira - Tarrytown NY, US
Lauren Gurski - Tarrytown NY, US
Aris Baras - Tarrytown NY, US
Meghan Drummond Samuelson - Tarrytown NY, US
Goncalo Abecasis - Tarrytown NY, US
International Classification:
C07K 14/47
C12Q 1/6827
G01N 33/53
G01N 33/68
C12Q 1/6874
Abstract:
The present disclosure provides methods of treating subjects having hearing loss, methods of identifying subjects having an increased risk of developing hearing loss, and methods of detecting human Fascin-2 (FSCN2) variant nucleic acid molecules and variant polypeptides.

Isbn (Books And Publications)

Ponti Medievali In Legno

Author:
Giovanni Coppola
ISBN #:
8842051055

Possible Relatives

David D Coppola  Dana M Coppola  Daniel A Coppola  Dominick G Coppola  Donna R Coppola  Ernesto E Coppola  Fred A Coppola  Giovanni E Leone  Giovanni Lepore  Giovanni Longo 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.